GL1X · GenesisL1 explorer

MolNFT v1 · #133329 · protein

Pandda analysis group deposition -- crystal structure of SARS-cov-2 NSP3 macrodomain in complex with ZINC000013514509

5RVO · Non-structural protein 3: “Pandda analysis group deposition -- crystal structure of SARS-cov-2 NSP3 macrodomain in complex with…”. X-ray diffraction, 1 ligand (AQO), 1 pocket (best druggability 0.55). MolNFT v1 #133329 on GenesisL1…

PDB
5RVO
Type
protein
Length
168 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 3
EC
3.4.19.121, 3.4.22.-
UniProt
P0DTD1
Ligands
AQO
Pockets
1 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein16842% helix, 20% strandP0DTD1

Ligands and binding sites

  • AQO · 2-aminoquinazolin-4(3H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11980.550.7832AQO

Compared structures

  • 5RVO · PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.